RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 14 - per page Next page
Order by
Novel target anti-lung cancer siRNA therapies, treatment drugs
Neomics has found a very promising target, AIMP2/AIMP2-DX2 for siRNA therapy application to tumoric lung cancer cells and we intend to focus the remaining resources on developing through clinical trials, the siRNA therapy as a first priority More
Conjugates of Ligand, Linker, and Cytotoxic Agent and Related Compositions and Methods of Use
The present invention describes cytotoxic compounds with an intracellular target that can selectively enter tumor cells through specific receptors on the cell surface. More
Treatment and Diagnosis of Cancer, Diabetes and Other Disorders Using Adrenomedullin Peptides and Antibodies
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
Human Monoclonal Antibody Against Mesothelin
An anti-mesothelin antibody of human origin has been generated; it has the ability to efficiently recognize mesothelin on the surface of cells, and induce ADCC in mesothelin-positive cells. More
Pharmaceutical Compositions and Methods for Preventing Skin Tumor Formation and Causing Regression of Existing Tumors
The compositions and methods of administration described in this invention are based on indole carbazole, which causes terminal differentiation of tumor cells by exploiting a normal physiologic pathway. More
Telomerase Suppressor Compositions and Methods for Diagnosis and Treatment of Cancer
Unique genetic changes in CCDC36 gene that are associated with early onset lung cancer More
Megakaryocyte Potentiation Factor as a New Serum Tumor Marker for Mesothelioma
New monoclonal antibodies against megakaryocyte potentiation factor More
Methods of Determining the Prognosis of an Adenocarcinoma
A novel method for determining the prognosis of a subject with adenocarcinoma in an organ and to aid in the selection of a specific therapeutic regimen. More
Prostatic Adenocarcinoma Cells Expressing or Lacking the Tumor Suppressor Gene PTEN
These cell lines can be used to study the role of the PTEN gene in cancer growth and metastasis. More
Magnetic nanoparticles for the treatment of illness
CSIC has developed a magnetic nanoparticle which contains at least an active ingredient, which can be used for the treatment of cancer. It can be injected intravenously and targeted to the region of interest using an external magnetic field. More
Displaying 1..10 of 14 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Lung Cancer and Non-Small Cell Lung Cancer Therapy Area Pipeline Report
Nov 2010 - 1535 pages - $1,495
Epidemiology: Non-Small Cell Lung Cancer – Despite global efforts to stop smoking, incidence rates will remain unchanged
Nov 2011 - 48 pages - $5,700
Lung Cancer: Global Incidence, Prevalence and Mortality to 2015
Jul 2010 - 135 pages - $1,740
Lung Cancer - Pipeline Review, Q3 2011
Jul 2011 - 837 pages - $500
Chinese Society of Lung Cancer – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 26 pages - $500
Spanish Lung Cancer Group – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 28 pages - $500
Metastatic Lung Cancer - Pipeline Review, Q4 2010
Dec 2010 - 29 pages - $500
Non-Small Cell Lung Cancer - Pipeline Review, Q1 2011
Feb 2011 - 538 pages - $500
European Lung Cancer Working Party – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 26 pages - $500
Small-Cell Lung Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 - 81 pages - $1,000
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us